AI is being used to model gene regulation and predict cellular behavior from transcriptomic data. Learn how these tools aid ...

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...

To request a FREE 2-week trial subscription, please signup. NOTE - this can take up to 48hrs to be approved.

The clinical-stage biotech is developing gene-editing CRISPR technology. Editas has reported encouraging testing results in ...

A new study reveals that transplanting healthy human glial progenitor cells into adult mice with Huntington’s disease can delay motor and cognitive decline and extend lifespan.

Huntington's disease has long defied attempts to rescue suffering neurons. A new study in Cell Reports shows that ...

Our cells constantly communicate, but it's hard to know if their receptor locks are truly active. A new tool, RIDDEN, analyzes gene patterns to predict receptor activity, revealing insights into ...

A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile. | A second patient has ...

Sarepta's stock drops on ELEVIDYS safety concerns, yet potential remains for ambulatory patients. Click here to read an ...

LONDON, GREATER LONDON, UNITED KINGDOM, June 16, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...